INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2023

Incorporating a plant-based diet was reported to improve remission and relapse outcomes in Crohn's disease and ulcerative colitis.

The authors review dietary factors in inflammatory bowel disease and describe outcomes incorporating a lacto-ovo-semi-vegetarian plant-based diet (PBD) into inpatient and post-discharge practice. First-line therapy with infliximab and PBD achieved a remission rate of 96% (44/46) in Crohn's disease (CD) and 76% (13/17) in severe ulcerative colitis (UC). In CD, a relapse-free outcome was achieved in 52% of patients at 10-year follow-up without biologics or immunosuppressants, while cumulative relapse rates for 51 initial episode UC cases at 1 and 5 years were 14% and 27%, respectively. Additionally, PBD alone induced remission without medication in approximately one-third of mild UC cases.

Study type
Narrative review with clinical case series data
Who was studied
Patients with Crohn's disease and ulcerative colitis
What was measured
Remission and relapse rates in Crohn's disease and ulcerative colitis

THE PAPER

Therapeutic advancement in inflammatory bowel disease by incorporating plant-based diet.

Chiba M, Tsuji T, Komatsu M. Transl Gastroenterol Hepatol, 2023.

PubMed 38021365 ↗DOI 10.1016/j.clinthera.2022.04.008 ↗

Gut & microbiome

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.